Expert Insights From Our
Financial Network with
Your free resource for the best articles, analysis, and investment ideas from across MarketWise (Nasdaq: MKTW) and our affiliates.
Every day, MarketWise Daily details the biggest stories from the market… giving you access to our exclusive publishing network of brands, experts, and analysts.
With hundreds of years of combined market knowledge across our network, these daily insights highlight the most important themes, sectors, and stocks you need to know about right now.
Join MarketWise Daily & Gain Insights From Our Network
By entering your email, you are agreeing to receive MarketWise Daily, and will also begin receiving occasional marketing messages from MarketWise. You can unsubscribe at any time. View our privacy policy.
Explore Our Network of
Publishers and Affiliates
MarketWise’s network of brands and affiliates are founded on two core principles: trustworthiness and providing the best financial insights possible.
Each of them is unique and offers their own perspective on the constantly changing market conditions and landscape.
Across our network, you’ll find technical traders, institutional investors, fundamental analysts, forensic accountants, and plenty of cutting-edge technology.
With MarketWise’s ever-growing network, you’re guaranteed to discover unique and valuable insights that you can’t find anywhere else. We are confident in that. We are MarketWise.
Our Companies
We’re a group of individual operating companies with one goal in mind: to empower investors.
Altimetry is a boutique financial research and publishing firm providing unique, unbiased investment recommendations and analytics.
Primarily, they are guided by the knowledge that U.S. accounting guidelines — which American public companies are required to follow — can obscure the true results of a company’s profitability, misleading or confusing investors. Their team deconstructs metrics under U.S. accounting guidelines and reassembles them using uniform accounting, which gives the true picture of a company’s potential.
At Brownstone Research, they deliver executive-level, proprietary research to anyone seeking an edge in the markets.
For too long, the best investment research has typically been reserved for investment banks and venture capital firms.
Their founder, Jeff Brown has witnessed the wealth-creating potential of disruptive technology. Using his 30+ years of technology and investing expertise, Jeff pinpoints companies on the verge of exponential growth and illuminates bleeding-edge trends with potential to drastically grow investors’ wealth.
Make great investments, manage risk, and find the market’s next big opportunities using Chaikin Analytics’ award-winning technology and research, built by stock market expert Marc Chaikin.
At the core of Chaikin Analytics is the Power Gauge stock and ETF rating system, which combines fundamental and technical factors to help pinpoint opportunities before Wall Street.
Chaikin’s “done for you” research saves investors time, shows them how to profit, and helps them understand how markets impact investments.
InvestorPlace is one of America’s largest, longest-standing independent financial research firms.
Their analysts and researchers are obsessively focused on providing readers with the biggest opportunities FIRST… Something they’ve proudly accomplished for well over 40 years.
They do so by not only alerting their members to massive trends… but also by warning of big dangers. And when there’s an opportunity to make big gains, they inform their members through useful, interesting, and — most importantly — ACTIONABLE research and recommendations.
Stansberry Research was founded in 1999 as an independent financial publisher. They care deeply about giving their subscribers the information they’d most want to receive if their roles were reversed.
Today, they publish several dozen investment research products — covering value investing, income generation, credit opportunities, natural resources, biotech, macroeconomic analysis, options trading, and more… as well as a fully integrated investment research platform at StansberryResearch.com. This platform distributes their research in real time, along with a complete set of data and analytical tools, including the proprietary models they use to build their research products.
TradeSmith began as a simple way to track portfolios using trailing stops, and has evolved into a powerful suite of risk-management and portfolio analysis tools.
Since 2005, they’ve been optimizing the powerful, proprietary algorithms behind their portfolio management software. This suite of tools features volatility-based buy and sell alerts, stock screener tools, a robust ratings system, and a groundbreaking options trading tool.
TradeSmith’s tools can be used on stocks, cryptocurrencies, commodities and funds to help limit risk and maximize upside. TradeSmith empowers individual, self-directed investors by giving them a tremendous edge in the markets.
Wide Moat Research believes the formula for long-term wealth creation is straightforward, but never easy. They help subscribers identify “wide moat businesses” trading at attractive valuations while paying reliable — and reliably rising — dividends.
Its founder and lead analyst, Brad Thomas, is a former real estate developer and longtime value investor. Before joining MarketWise, Brad was one of the most widely read analysts on Seeking Alpha, with more than 100,000 followers. Brad is the author of three real estate investing books — including his latest, REITs for Dummies.
Recent Articles
Don’t Count Out Small-Caps
In today’s email: Biden drops out: President won’t seek re-election, adding to election volatility. Here come the small caps: Russell 2000 surges 11% in just five trading days. Finding gai...
AI Will Send Markets Into a Panic
In today’s email: CrowdStrike outage: Software issues hit planes, banks, and the London Stock Exchange. Ford giving up on EVs?: Auto giant reallocates money back to gas-powered vehicles. An urge...
Don’t Worry If Stocks Take a Breather
In today’s email: Weight-loss competition: Roche becomes the latest pharma giant with a weight-loss pill, driving Novo Nordisk and Eli Lilly shares lower. Chips lead markets lower: Comments from...